Abdulkadir Tunc赞助的临床试验
总计447个结果
-
UNC Lineberger Comprehensive Cancer Center终止
-
UNC Lineberger Comprehensive Cancer Center完全的
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline完全的不可切除的黑色素瘤 | IV 期黑色素瘤 | III期黑色素瘤 | BRAF 突变型黑色素瘤美国
-
UNC Lineberger Comprehensive Cancer CenterPfizer终止
-
National Yang Ming Chiao Tung University Hospital完全的
-
UNC Lineberger Comprehensive Cancer CenterUNC Cecil G. Sheps Center for Health Services Research完全的
-
UNC Lineberger Comprehensive Cancer CenterAstraZeneca主动,不招人
-
UNC Lineberger Comprehensive Cancer CenterCelgene完全的
-
UNC Lineberger Comprehensive Cancer CenterAstraZeneca完全的
-
UNC Lineberger Comprehensive Cancer CenterBayer完全的
-
UNC Lineberger Comprehensive Cancer CenterCelgene完全的
-
UNC Lineberger Comprehensive Cancer CenterPfizer终止
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline完全的
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline完全的
-
SanofiUNC Lineberger Comprehensive Cancer Center完全的脑转移 | 雌激素受体阴性(ER 阴性)乳腺癌 | 孕激素受体阴性(PR-阴性)乳腺癌 | 人类表皮生长因子受体 2 阴性 (HER2-Negative) 乳腺癌美国
-
The Hong Kong Polytechnic UniversityTung Wah College尚未招聘
-
Kwong Wah HospitalTung Wah Group of Hospitals未知
-
The Hong Kong Polytechnic UniversityTung Wah College; Mindvivid尚未招聘身体虚弱 | 身体构成 | 认知功能 | 营养 | 认知脆弱 | Protective Diet Adherence
-
UNC Lineberger Comprehensive Cancer CenterAstraZeneca招聘中
-
UNC Lineberger Comprehensive Cancer CenterAmgen完全的
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline主动,不招人
-
UNC Lineberger Comprehensive Cancer CenterSanofi完全的
-
UNC Lineberger Comprehensive Cancer CenterCephalon完全的
-
UNC Lineberger Comprehensive Cancer CenterGlaxoSmithKline撤销淋巴瘤,滤泡性 | 淋巴瘤,非霍奇金 | 淋巴瘤、B 细胞、边缘区 | 淋巴瘤,低级别 | 淋巴瘤,中级
-
UNC Lineberger Comprehensive Cancer CenterSyndax Pharmaceuticals完全的
-
UNC Lineberger Comprehensive Cancer CenterSeagen Inc.完全的
-
UNC Lineberger Comprehensive Cancer CenterIncyte Corporation撤销乳腺癌 | 乳腺肿瘤 | 三阴性乳腺癌 | HER2阳性乳腺癌
-
UNC Lineberger Comprehensive Cancer CenterGenentech, Inc.终止
-
UNC Lineberger Comprehensive Cancer CenterAstraZeneca; Amgen完全的